@crmartin90 @DrAbdulRazak_MD @EBNEO @JAMA_current @NEJM @NeoResearch_Net Great summary, Cami. Thanks What are your thoughts on lipid formulations which also contain variable amounts of DHA and ARA? A few years ago we retrospectively compared use of two ty
Inpatient outcomes of preterm infants receiving ω-3 enriched lipid emulsion (SMOFlipid): an observational study. https://t.co/oZgCCxKmRm https://t.co/yFr5A2ob89
RT @EurJPediatrics: Inpatient outcomes of #preterm #infants receivingω-3 enriched lipid emulsion (SMOFlipid): an observational study https:…
Inpatient outcomes of #preterm #infants receivingω-3 enriched lipid emulsion (SMOFlipid): an observational study https://t.co/IZZ8yqgKUE
Inpatient outcomes of preterm infants receiving ω-3 enriched lipid emulsion (SMOFlipid): an observational study https://t.co/kTTMIAsMNU
#EuropeanJournalOfPediatrics Inpatient outcomes of preterm infants receiving ω-3 enriched lipid emulsion (SMOFlipid): an observational study https://t.co/kneVYW1Qmx
RT @ContinuumAEP: #EuropeanJournalOfPediatrics Inpatient outcomes of preterm infants receiving ω-3 enriched lipid emulsion (SMOFlipid): an…
Inpatient outcomes of preterm infants receiving ω-3 enriched lipid emulsion (SMOFlipid): an observational study https://t.co/WkmmLc1guA
#EuropeanJournalOfPediatrics Inpatient outcomes of preterm infants receiving ω-3 enriched lipid emulsion (SMOFlipid): an observational study https://t.co/y7pCyFnKtF